摘要
<正>系统性红斑狼疮(systemic lupus erythemato?sus,SLE)是临床常见的一种多系统损害的自身免疫性疾病。其临床表现多样,病情进展快、预后不良,已引起临床医生的广泛关注。巨噬细胞活化综合征(macrophage activation syndrome,MAS)是一种严重的自身炎症性疾病,病死率高达20%~30%~([1]),常继发于感染性疾病、恶性肿瘤和多种风湿性疾病,其原因是不受控制地产生促炎性细胞
引文
[1]姜楠,李梦涛,吴迪,等.系统性红斑狼疮继发巨噬细胞活化综合征15例临床分析[J].中华内科杂志,2016,55(11):840-844.
[2]Kumakura S,Murakawa Y.Clinical characteristics and treat?ment outcomes of autoimmune-associated hemophagocytic syn?drome in adults[J].Arthritis Rheumatol,2014,66(8):2297-2307.
[3]Lambotte O,Khellaf M,Harmouche H,et al.Characteristics and long-term outcome of 15 episodes of systemic lupus erythe?matosus-associated hemophagocytic syndrome[J].Medicine,2006,85(3):169-182.
[4]Fukaya S,Yasuda S,Hashimoto T,et al.Clinical features of haemophagocytic syndrome in patients with systemic autoim?mune diseases:analysis of 30 cases[J].Rheumatology,2008,47(11):1686-1691.
[5]Sumegi J,Barnes MG,Nestheide SV,et al.Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis[J].Blood,2011,117(15):e151-160.
[6]Schulert GS,Grom AA.Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies[J].An?nu Rev Med,2015,66:145-159.
[7]Gavand PE,Serio I,Arnaud L,et al.Clinical spectrum and therapeutic management of systemic lupus erythematosus-asso?ciated macrophage activation syndrome:A study of 103 episodes in 89 adult patients[J].Autoimmun Rev,2017,16(7):743-749.
[8]Liu AC,Yang Y,Li MT,et al.Macrophage activation syn?drome in systemic lupus erythematosus:A multicenter,casecontrol study in China[J].Clin Rheumatol,2018,37(1):93-100.
[9]Parodi A,DavìS,Pringe AB,et al.Macrophage activation syn?drome in juvenile systemic lupus erythematosus:a multination?al multicenter study of thirty-eight patients[J].Arthritis Rheum,2009,60(11):3388-3399.
[10]Minoia F,DavìS,Horne A,et al.Clinical features,treatment,and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis:a multinational,multicenter study of 362 patients[J].Arthritis Rheumatol,2014,66(11):3160-3169.
[11]Kostik MM,Dubko MF,Masalova VV,et al.Identification of the best cutoff points and clinical signs specific for early recog?nition of macrophage activation syndrome in active systemic ju?venile idiopathic arthritis[J].Semin Arthritis Rheum,2015,44(4):417-422.
[12]马慧慧,钱小青,俞海国,等.儿童巨噬细胞活化综合征23例临床分析[J].东南大学学报(医学版),2012,31(6):736-738.
[13]Cron RQ,Davi S,Minoia F,et al.Clinical features and cor?rect diagnosis of macrophage activation syndrome[J].Expert Rev Clin Immunol,2015,11(9):1043-1053.
[14]崔琬麟,张乾忠,张岩,姜红.系统性红斑狼疮并发巨噬细胞活化综合征3例临床分析[J].中国实用儿科杂志,2016,31(08):619-621.
[15]姜楠,李梦涛,吴迪,等.系统性红斑狼疮继发巨噬细胞活化综合征15例临床分析[J].中华内科杂志,2016,55(11):840-844.
[16]Lattanzi B,Davi S,Rosina S,et al.Macrophage activation syndrome[J].Indian J Rheumatol,2012,7(1-supp-S):27-35.
[17]Aoyama-Maeda N,Horino T,Ichii O,et al.Macrophage acti?vation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse,im?munoglobulin and tacrolimus[J].Rom J Intern Med,2018,56(2):117-121.
[18]陈香元,曾华松,曾萍.慢性风湿性疾病中的危急重症--巨噬细胞活化综合征[J].中国实用儿科杂志,2018,33(4):306-308.